{"id":1740558,"date":"2025-09-18T16:31:32","date_gmt":"2025-09-18T11:01:32","guid":{"rendered":"https:\/\/pharmint.net\/?post_type=encyclopedia&#038;p=1740558"},"modified":"2025-09-18T16:34:30","modified_gmt":"2025-09-18T11:04:30","slug":"api-sourcing","status":"publish","type":"encyclopedia","link":"https:\/\/pharmint.net\/ar\/glossary\/api-sourcing\/","title":{"rendered":"API Sourcing"},"content":{"rendered":"<h3><a href=\"https:\/\/pharmint.net\/glossary\/api-sourcing\/\"><strong>What is API Sourcing?<\/strong><\/a><\/h3>\n<p><strong>API Sourcing<\/strong><span style=\"font-weight: 400;\">&nbsp;refers to the process by which pharmaceutical companies,&nbsp;<\/span><a href=\"https:\/\/pharmint.net\/glossary\/contract-development-manufacturing-organization-cdmo\/\"><span style=\"font-weight: 400;\">CDMOs<\/span><\/a><span style=\"font-weight: 400;\">, or buyers identify, evaluate, select, qualify, and procure&nbsp;<\/span><a href=\"https:\/\/pharmint.net\/product-category\/pharma-ingredients-raw-materials\/\"><span style=\"font-weight: 400;\">Active Pharmaceutical Ingredients<\/span><\/a><span style=\"font-weight: 400;\">&nbsp;(APIs) from reliable manufacturers or suppliers. It encompasses regulatory, quality, ethical, logistical, and supply chain risk aspects to ensure that APIs meet pharmacopeial,&nbsp;<\/span><a href=\"https:\/\/pharmint.net\/glossary\/good-manufacturing-practice-gmp\/\"><span style=\"font-weight: 400;\">GMP<\/span><\/a><span style=\"font-weight: 400;\">, safety, and specification requirements before being used in drug formulations.<\/span><\/p>\n<h3><strong>Why Is API Sourcing Critical for the Pharma Industry?<\/strong><\/h3>\n<ul>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Ensures&nbsp;<\/span><strong>compliance with&nbsp;<\/strong><a href=\"https:\/\/pharmint.net\/glossary\/current-good-manufacturing-practice-cgmp\/\"><strong>cGMP<\/strong><\/a><strong>&nbsp;and regulatory guidelines<\/strong><span style=\"font-weight: 400;\">&nbsp;(e.g., FDA&rsquo;s Q7A guidance for APIs) so that APIs are consistently safe, potent, and of high purity.<\/span><span style=\"font-weight: 400;\"><br>\n<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Prevents risks of adulteration, counterfeit API, or poor&#8209;quality ingredients, which can affect efficacy, safety, and market approval.<\/span><span style=\"font-weight: 400;\"><br>\n<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Supports supply reliability and business continuity. Sourcing from trusted suppliers mitigates disruptions, quality failures, or regulatory issues in multiple markets.<\/span><span style=\"font-weight: 400;\"><br>\n<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Facilitates documentation, traceability (<\/span><a href=\"https:\/\/pharmint.net\/glossary\/certificate-of-analysis-coa\/\"><span style=\"font-weight: 400;\">COA<\/span><\/a><span style=\"font-weight: 400;\">, change control), and transparency&mdash;crucial for audits, regulatory filings (<\/span><a href=\"https:\/\/pharmint.net\/glossary\/dmf-drug-master-file\/\"><span style=\"font-weight: 400;\">DMFs<\/span><\/a><span style=\"font-weight: 400;\">, CMC), and pharmacovigilance.<\/span><span style=\"font-weight: 400;\"><br>\n<\/span><\/li>\n<\/ul>\n<h3><strong>What Are the Core Principles Behind Good API Sourcing?<\/strong><\/h3>\n<ul>\n<li style=\"font-weight: 400;\"><strong>Regulatory &amp; GMP Compliance<\/strong><span style=\"font-weight: 400;\">: The supplier must follow current GMP for API manufacture (e.g., ICH Q7 \/ FDA Q7A) and be registered\/licensed with relevant authorities.<\/span><span style=\"font-weight: 400;\"><br>\n<\/span><\/li>\n<li style=\"font-weight: 400;\"><strong>Supplier Qualification &amp; Audit<\/strong><span style=\"font-weight: 400;\">: On&#8209;site audits, technical due diligence, historical performance, facility capability, inspection records.<\/span><span style=\"font-weight: 400;\"><br>\n<\/span><\/li>\n<li style=\"font-weight: 400;\"><strong>Quality Assurance &amp; Documentation<\/strong><span style=\"font-weight: 400;\">: Full <a href=\"https:\/\/pharmint.net\/ar\/glossary\/certificate-of-analysis-coa\/\" target=\"_self\" title=\"What Is a Certificate of Analysis (COA)? A&nbsp;Certificate of Analysis (COA)&nbsp;is an official, batch-specific document issued by a manufacturer or quality control lab that verifies a product's identity, strength, purity, and conformance to predefined specifications. It's essential for quality assurance and regulatory compliance across&nbsp;APIs,&nbsp;excipients,&nbsp;drugs, and reference materials. Why Is a COA Important in the Pharma&hellip;\" class=\"encyclopedia\">Certificate of Analysis (COA)<\/a>, traceable&nbsp;<\/span><a href=\"https:\/\/pharmint.net\/glossary\/raw-material\/\"><span style=\"font-weight: 400;\">raw material<\/span><\/a><span style=\"font-weight: 400;\">&nbsp;sources, validated test methods,&nbsp;<\/span><a href=\"https:\/\/pharmint.net\/glossary\/impurity-profile\/\"><span style=\"font-weight: 400;\">impurity profile<\/span><\/a><span style=\"font-weight: 400;\">, and retention of samples.<\/span><span style=\"font-weight: 400;\"><br>\n<\/span><\/li>\n<li style=\"font-weight: 400;\"><strong>Risk Management<\/strong><span style=\"font-weight: 400;\">: Risk assessment for supply chain vulnerabilities (single sourcing, <a href=\"https:\/\/pharmint.net\/ar\/glossary\/raw-material\/\" target=\"_self\" title=\"What Is a Raw Material in Pharmaceutical Manufacturing? A&nbsp;raw material&nbsp;in the pharmaceutical industry refers to any unprocessed or minimally processed substance used at the beginning of a synthesis or formulation process. These materials include solvents, reagents, minerals, plant extracts, and basic chemicals that transform the manufacture of pharmaceutical intermediates, APIs, or excipients. Why Are Raw&hellip;\" class=\"encyclopedia\">raw material<\/a> shortages, geopolitical risks), regulatory changes, intellectual property\/patent issues.<\/span><span style=\"font-weight: 400;\"><br>\n<\/span><\/li>\n<li style=\"font-weight: 400;\"><strong>Transparency &amp; Ethics<\/strong><span style=\"font-weight: 400;\">: Clear disclosure of supplier identity, manufacturing steps, location, compliance history; avoiding brokers who cannot trace source reliably.<\/span><span style=\"font-weight: 400;\"><br>\n<\/span><\/li>\n<\/ul>\n<h3><strong>How Does API Sourcing Work in Practice (Pharma Supply Chain)?<\/strong><\/h3>\n<ol>\n<li style=\"font-weight: 400;\"><strong>Define Specifications and Regulatory Requirements:&nbsp;<\/strong><span style=\"font-weight: 400;\">The pharma buyer defines required specifications: assay, purity, impurity limits, <a href=\"https:\/\/pharmint.net\/ar\/glossary\/pharmacopeial-compliance\/\" target=\"_self\" title=\"What is Pharmacopeial Compliance? Pharmacopeial Compliance is the practice by which pharmaceutical manufacturers, suppliers, and distributors ensure their materials, drug substances, drug products, and&nbsp;excipients&nbsp;conform to the standards (monographs, test methods, acceptance criteria) published in one or more&nbsp;official pharmacopeias,&nbsp;such as: USP&#8209;NF, European Pharmacopoeia, Indian Pharmacopoeia, Japanese Pharmacopeia, etc.. Compliance includes keeping up with current versions, performing&hellip;\" class=\"encyclopedia\">pharmacopeial compliance<\/a>, starting materials, and legal\/regulatory constraints (e.g., whether API must be made in a facility inspected by certain regulators).<\/span><span style=\"font-weight: 400;\"><br>\n<\/span><\/li>\n<li style=\"font-weight: 400;\"><strong>Supplier Identification &amp; Pre&#8209;Qualification:&nbsp;<\/strong><span style=\"font-weight: 400;\">Identify potential API manufacturers. Evaluate their regulatory certifications (GMP, FDA, EMA, other national authorities), past performance, capacity, and geographic location.<\/span><span style=\"font-weight: 400;\"><br>\n<\/span><\/li>\n<li style=\"font-weight: 400;\"><strong>Due Diligence &amp; Audits:&nbsp;<\/strong><span style=\"font-weight: 400;\">Conduct facility audits (on&#8209;site or virtual), verify documentation, review inspection histories, check <a href=\"https:\/\/pharmint.net\/ar\/glossary\/raw-material\/\" target=\"_self\" title=\"What Is a Raw Material in Pharmaceutical Manufacturing? A&nbsp;raw material&nbsp;in the pharmaceutical industry refers to any unprocessed or minimally processed substance used at the beginning of a synthesis or formulation process. These materials include solvents, reagents, minerals, plant extracts, and basic chemicals that transform the manufacture of pharmaceutical intermediates, APIs, or excipients. Why Are Raw&hellip;\" class=\"encyclopedia\">raw material<\/a> sourcing, <a href=\"https:\/\/pharmint.net\/ar\/glossary\/impurity-profile\/\" target=\"_self\" title=\"What Is an Impurity Profile? An&nbsp;impurity profile&nbsp;is a comprehensive characterization of&nbsp;identified and unidentified impurities&nbsp;in a drug substance or pharmaceutical product. According to ICH Q7, this profile should include qualitative or structural identification (like retention time), observed impurity ranges, and classification of impurities (e.g., organic, inorganic, solvent). Why Is Impurity Profiling Critical in Pharmaceuticals? Impurity profiling&hellip;\" class=\"encyclopedia\">impurity profile<\/a>s, and stability data.<\/span><span style=\"font-weight: 400;\"><br>\n<\/span><\/li>\n<li style=\"font-weight: 400;\"><strong>Sample Testing &amp; Validation:&nbsp;<\/strong><span style=\"font-weight: 400;\">Obtain representative samples of the API. Conduct identity, potency\/assay, impurity, and stability tests, and confirm COA matches specifications.<\/span><span style=\"font-weight: 400;\"><br>\n<\/span><\/li>\n<li style=\"font-weight: 400;\"><strong>Contractual and Quality Agreements:&nbsp;<\/strong><span style=\"font-weight: 400;\">Secure quality agreement covering change control, supply reliability, documentation (COA, DMF \/ ASMF), GMP compliance, and regulatory responsibilities.<\/span><span style=\"font-weight: 400;\"><br>\n<\/span><\/li>\n<li style=\"font-weight: 400;\"><strong>Ongoing Monitoring &amp; Requalification<\/strong><span style=\"font-weight: 400;\">: Monitor batch consistency, perform periodic audits, and update qualification if there are changes in process, regulation, or supplier ownership.<\/span><span style=\"font-weight: 400;\"><br>\n<\/span><\/li>\n<li style=\"font-weight: 400;\"><strong>Supply Chain &amp; Logistics Management:&nbsp;<\/strong><span style=\"font-weight: 400;\">Ensure appropriate handling, storage, packaging, and transport to maintain API integrity. Include traceability from <a href=\"https:\/\/pharmint.net\/ar\/glossary\/raw-material\/\" target=\"_self\" title=\"What Is a Raw Material in Pharmaceutical Manufacturing? A&nbsp;raw material&nbsp;in the pharmaceutical industry refers to any unprocessed or minimally processed substance used at the beginning of a synthesis or formulation process. These materials include solvents, reagents, minerals, plant extracts, and basic chemicals that transform the manufacture of pharmaceutical intermediates, APIs, or excipients. Why Are Raw&hellip;\" class=\"encyclopedia\">raw material<\/a>s to finished shipments.<\/span><span style=\"font-weight: 400;\"><br>\n<\/span><\/li>\n<\/ol>\n<h3><strong>Real&#8209;World Examples of API Sourcing in Action<\/strong><\/h3>\n<ul>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">A <a href=\"https:\/\/pharmint.net\/glossary\/contract-development-manufacturing-organization-cdmo\/\">CDMO<\/a> sourcing an API for generic drug production ensures that the manufacturer is audited and has a valid ICH Q7 \/ FDA Q7A GMP certificate before placing a long&#8209;term contract.<\/span><span style=\"font-weight: 400;\"><br>\n<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">A pharma company sourcing an API from overseas reviews the <a href=\"https:\/\/pharmint.net\/ar\/glossary\/impurity-profile\/\" target=\"_self\" title=\"What Is an Impurity Profile? An&nbsp;impurity profile&nbsp;is a comprehensive characterization of&nbsp;identified and unidentified impurities&nbsp;in a drug substance or pharmaceutical product. According to ICH Q7, this profile should include qualitative or structural identification (like retention time), observed impurity ranges, and classification of impurities (e.g., organic, inorganic, solvent). Why Is Impurity Profiling Critical in Pharmaceuticals? Impurity profiling&hellip;\" class=\"encyclopedia\">impurity profile<\/a> and stability data of the API compared to the previous source and mandates an updated COA.<\/span><span style=\"font-weight: 400;\"><br>\n<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">When regulatory authorities require the designation of &ldquo;starting materials&rdquo; per ICH Q11, the sourcing process includes verifying that materials used upstream meet RSM criteria.<\/span><span style=\"font-weight: 400;\"><br>\n<\/span><\/li>\n<\/ul>\n<h3><strong>Related Terms and Concepts<\/strong><\/h3>\n<ul>\n<li style=\"font-weight: 400;\"><a href=\"https:\/\/pharmint.net\/what-is-active-pharmaceutical-ingredient-api\/\"><span style=\"font-weight: 400;\">Active Pharmaceutical Ingredient (API)<\/span><\/a><span style=\"font-weight: 400;\">&nbsp;&ndash; the substance being sourced.<\/span><span style=\"font-weight: 400;\"><br>\n<\/span><\/li>\n<li style=\"font-weight: 400;\"><a href=\"https:\/\/pharmint.net\/glossary\/certificate-of-analysis-coa\/\"><span style=\"font-weight: 400;\">Certificate of Analysis (COA)<\/span><\/a><span style=\"font-weight: 400;\">&nbsp;&ndash; key documentation in sourcing.<\/span><span style=\"font-weight: 400;\"><br>\n<\/span><\/li>\n<li style=\"font-weight: 400;\"><a href=\"https:\/\/pharmint.net\/glossary\/good-manufacturing-practice-gmp\/\"><span style=\"font-weight: 400;\">Good Manufacturing Practice (GMP)<\/span><\/a><span style=\"font-weight: 400;\">&nbsp;&ndash; required for API source compliance.<\/span><span style=\"font-weight: 400;\"><br>\n<\/span><\/li>\n<li style=\"font-weight: 400;\"><a href=\"https:\/\/pharmint.net\/glossary\/dmf-drug-master-file\/\"><span style=\"font-weight: 400;\">Drug Master File (DMF)<\/span><\/a><span style=\"font-weight: 400;\">&nbsp;&ndash; often used by suppliers to share confidential manufacturing info.<\/span><span style=\"font-weight: 400;\"><br>\n<\/span><\/li>\n<li style=\"font-weight: 400;\"><a href=\"https:\/\/pharmint.net\/glossary\/impurity-profile\/\"><span style=\"font-weight: 400;\">Impurity Profile<\/span><\/a><span style=\"font-weight: 400;\">&nbsp;&ndash; crucial in evaluating API quality.<\/span><span style=\"font-weight: 400;\"><br>\n<\/span><\/li>\n<\/ul>\n<h2><strong>API Sourcing FAQs<\/strong><\/h2>\n<h4><strong>What regulatory guidelines govern API sourcing?<\/strong><\/h4>\n<p><span style=\"font-weight: 400;\">Guidelines like ICH Q7 \/ FDA Q7A, ICH Q11, and pharmacopeial standards govern GMP, impurity control, starting material definitions, and supplier qualifications<\/span><\/p>\n<p><strong>How do I verify the GMP status of an API supplier?<\/strong><\/p>\n<p><span style=\"font-weight: 400;\">Check regulatory registrations, past inspection or audit reports, GMP certificates, compliance history with agencies like the FDA, EMA, or national drug regulatory authorities.<\/span><\/p>\n<h4><strong>Why is impurity profiling important during API sourcing?<\/strong><\/h4>\n<p><span style=\"font-weight: 400;\">It ensures the API does not contain harmful or unexpected impurities, traces its source, and meets safety\/purity thresholds set by pharmacopeias and regulators.<\/span><\/p>\n<h4><strong>What is a Starting Material, and why is designation critical?<\/strong><\/h4>\n<p><span style=\"font-weight: 400;\">A Starting Material is a <a href=\"https:\/\/pharmint.net\/ar\/glossary\/raw-material\/\" target=\"_self\" title=\"What Is a Raw Material in Pharmaceutical Manufacturing? A&nbsp;raw material&nbsp;in the pharmaceutical industry refers to any unprocessed or minimally processed substance used at the beginning of a synthesis or formulation process. These materials include solvents, reagents, minerals, plant extracts, and basic chemicals that transform the manufacture of pharmaceutical intermediates, APIs, or excipients. Why Are Raw&hellip;\" class=\"encyclopedia\">raw material<\/a> or intermediate incorporated into the API. Proper designation under ICH Q11 helps define when GMP and regulatory controls begin.<\/span><\/p>\n<h4><strong>How should supply chain risks be managed in API sourcing?<\/strong><\/h4>\n<p><span style=\"font-weight: 400;\">Use multiple suppliers, assess geographic\/regulatory risk, audit frequently, ensure <a href=\"https:\/\/pharmint.net\/ar\/glossary\/raw-material\/\" target=\"_self\" title=\"What Is a Raw Material in Pharmaceutical Manufacturing? A&nbsp;raw material&nbsp;in the pharmaceutical industry refers to any unprocessed or minimally processed substance used at the beginning of a synthesis or formulation process. These materials include solvents, reagents, minerals, plant extracts, and basic chemicals that transform the manufacture of pharmaceutical intermediates, APIs, or excipients. Why Are Raw&hellip;\" class=\"encyclopedia\">raw material<\/a> traceability, and maintain buffer stocks.<\/span><\/p>\n<h4><strong>Can cost be balanced with quality in API sourcing?<\/strong><\/h4>\n<p><span style=\"font-weight: 400;\">Yes&mdash;but cost savings should not compromise GMP, impurity limits, quality agreements, or regulatory compliance. Choose based on value, not just price.<\/span><\/p>\n<h4><strong>What documentation should accompany sourced APIs?<\/strong><\/h4>\n<p><span style=\"font-weight: 400;\">COA, stability data, certificate of compliance or GMP certificate, DMF&#8208;\/ASMF references, test method specs, traceability of starting materials.<\/span><\/p>\n<h4><strong>Are consumers or downstream formulators liable for poorly sourced APIs?<\/strong><\/h4>\n<p><span style=\"font-weight: 400;\">Yes&mdash;if non&#8209;compliant APIs reach finished products, manufacturers, distributors, or marketers may be held accountable by regulators, possibly facing recalls or sanctions.<\/span><\/p>\n","protected":false},"author":7806,"template":"","meta":{"rank_math_lock_modified_date":false,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"set","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"ep_exclude_from_search":false},"encyclopedia-tag":[1543,1539,1540,1541,1542],"class_list":["post-1740558","encyclopedia","type-encyclopedia","status-publish","hentry","encyclopedia-tag-api-manufacturing-network","encyclopedia-tag-api-sourcing","encyclopedia-tag-bulk-api-procurement","encyclopedia-tag-gmp-certified-api-suppliers","encyclopedia-tag-pharmaceutical-sourcing"],"_links":{"self":[{"href":"https:\/\/pharmint.net\/ar\/wp-json\/wp\/v2\/encyclopedia\/1740558","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharmint.net\/ar\/wp-json\/wp\/v2\/encyclopedia"}],"about":[{"href":"https:\/\/pharmint.net\/ar\/wp-json\/wp\/v2\/types\/encyclopedia"}],"author":[{"embeddable":true,"href":"https:\/\/pharmint.net\/ar\/wp-json\/wp\/v2\/users\/7806"}],"wp:attachment":[{"href":"https:\/\/pharmint.net\/ar\/wp-json\/wp\/v2\/media?parent=1740558"}],"wp:term":[{"taxonomy":"encyclopedia-tag","embeddable":true,"href":"https:\/\/pharmint.net\/ar\/wp-json\/wp\/v2\/encyclopedia-tag?post=1740558"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}